According to a recent LinkedIn post from SeqOne, the company is promoting an upcoming webinar focused on implementing a scalable, automated comprehensive genomic profiling workflow in routine clinical practice. The session will feature a case study from the University Hospital of Split, highlighting how its solid tumor NGS workflow was streamlined using the SeqOne platform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests SeqOne is positioning its technology for broader clinical adoption in precision oncology, emphasizing consistency of interpretation across tumor types as a key challenge. For investors, this focus on real-world hospital use and automation may indicate efforts to deepen penetration in clinical genomics, potentially supporting recurring software revenue and strengthening the firm’s competitive stance in the CGP and NGS ecosystem.